Board of Scientific Counselors, National Center for Injury Prevention and Control, 41985 [2020-15029]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 134 / Monday, July 13, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control (BSC, NCIPC). This meeting
is partially open to the public. There
will be 15 minutes allotted for public
comments at the end of the open session
from 12:30 p.m. to 12:45 p.m. on August
20, 2020.
DATES: The meeting will be held on
August 20, 2020, from 10:00 a.m. to 1:00
p.m., EST (OPEN) and August 20, 2020,
from 1:30 p.m. to 5:00 p.m., EST
(CLOSED).
SUMMARY:
Teleconference 1–800–369–
3110; Participant Code 7563795
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop S106–9, Atlanta,
GA 30341, Telephone (770) 488–3953,
Email address: NCIPCBSC@cdc.gov.
SUPPLEMENTARY INFORMATION: Portions
of the meeting as designated above will
be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Strategic Business Initiatives Unit,
Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92–463.
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
BSC, NCIPC makes recommendations
jbell on DSKJLSW7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
20:25 Jul 10, 2020
Jkt 250001
regarding policies, strategies, objectives,
and priorities; reviews progress toward
injury prevention goals; and provides
evidence in injury prevention-related
research and programs. The Board also
provides advice on the appropriate
balance of intramural and extramural
research, and the structure, progress and
performance of intramural programs.
The Board is designed to provide
guidance on extramural scientific
program matters, including the: (1)
Review of extramural research concepts
for funding opportunity
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to funding opportunity
announcements as they relate to the
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios, and (5) review of
program proposals.
Matters to be Considered: The open
portion of the agenda will include
discussions on Health Equity, Violence,
and Racism. All presentations will be
followed by discussion by the BSC.
The closed portion of the agenda will
focus on the Secondary Peer Review of
extramural research grant applications
received in response to three (3) Notice
of Funding Opportunities (NOFOs):
RFA–CE–20–002—‘‘Grants to Support
New Investigators in Conducting
Research Related to Preventing
Interpersonal Violence Impacting
Children and Youth’’; RFA–CE–20–
005—‘‘Rigorously Evaluating
Approaches to Prevent AdultPerpetrated Child Sex Abuse (CSA)’’;
and RFA–CE–20–006—‘‘Research
Grants to Prevent Firearm-Related
Violence and Injuries (R01)’’, as well as
PA–19–272/273–PHS 2019–02
‘‘Omnibus Solicitation of the NIH, CDC,
and FDA for Small Business Innovation
Research Grant Applications’’ (Parent
SBIR [R43/R44]). Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
41985
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–15029 Filed 7–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0081]
Advisory Committee on Immunization
Practices (ACIP)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC, announces the following meeting
of the Advisory Committee on
Immunization Practices (ACIP). This
meeting is open to the public. Time will
be available for public comment. The
meeting will be webcast live via the
World Wide Web.
DATES: The meeting will be held on July
29, 2020, from 10 a.m. to 4 p.m., EDT
(times subject to change).
Written comments must be received
on or before July 30, 2020.
ADDRESSES: For more information on
ACIP please visit the ACIP website:
https://www.cdc.gov/vaccines/acip/
index.html.
You may submit comments, identified
by Docket No. CDC–2020–0081, by
either of the following methods below.
CDC does not accept comment by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket No. CDC–2020–0081,
c/o Attn: July ACIP Meeting, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H24–8, Atlanta,
GA 30329–4027.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
SUMMARY:
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 85, Number 134 (Monday, July 13, 2020)]
[Notices]
[Page 41985]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15029]
[[Page 41985]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control (BSC, NCIPC). This
meeting is partially open to the public. There will be 15 minutes
allotted for public comments at the end of the open session from 12:30
p.m. to 12:45 p.m. on August 20, 2020.
DATES: The meeting will be held on August 20, 2020, from 10:00 a.m. to
1:00 p.m., EST (OPEN) and August 20, 2020, from 1:30 p.m. to 5:00 p.m.,
EST (CLOSED).
ADDRESSES: Teleconference 1-800-369-3110; Participant Code 7563795
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop S106-9, Atlanta, GA 30341, Telephone (770)
488-3953, Email address: [email protected].
SUPPLEMENTARY INFORMATION: Portions of the meeting as designated above
will be closed to the public in accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to Public Law 92-463.
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The BSC, NCIPC makes
recommendations regarding policies, strategies, objectives, and
priorities; reviews progress toward injury prevention goals; and
provides evidence in injury prevention-related research and programs.
The Board also provides advice on the appropriate balance of intramural
and extramural research, and the structure, progress and performance of
intramural programs. The Board is designed to provide guidance on
extramural scientific program matters, including the: (1) Review of
extramural research concepts for funding opportunity announcements; (2)
conduct of Secondary Peer Review of extramural research grants,
cooperative agreements, and contracts applications received in response
to funding opportunity announcements as they relate to the Center's
programmatic balance and mission; (3) submission of secondary review
recommendations to the Center Director of applications to be considered
for funding support; (4) review of research portfolios, and (5) review
of program proposals.
Matters to be Considered: The open portion of the agenda will
include discussions on Health Equity, Violence, and Racism. All
presentations will be followed by discussion by the BSC.
The closed portion of the agenda will focus on the Secondary Peer
Review of extramural research grant applications received in response
to three (3) Notice of Funding Opportunities (NOFOs): RFA-CE-20-002--
``Grants to Support New Investigators in Conducting Research Related to
Preventing Interpersonal Violence Impacting Children and Youth''; RFA-
CE-20-005--``Rigorously Evaluating Approaches to Prevent Adult-
Perpetrated Child Sex Abuse (CSA)''; and RFA-CE-20-006--``Research
Grants to Prevent Firearm-Related Violence and Injuries (R01)'', as
well as PA-19-272/273-PHS 2019-02 ``Omnibus Solicitation of the NIH,
CDC, and FDA for Small Business Innovation Research Grant
Applications'' (Parent SBIR [R43/R44]). Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-15029 Filed 7-10-20; 8:45 am]
BILLING CODE 4163-18-P
